Third consecutive profitable quarter with continued strong growth
October 26, 2015 08:52 ET
|
Exiqon A/S
Copenhagen, 2015-10-26 13:52 CET (GLOBE NEWSWIRE) --
Exiqon A/S (NASDAQ OMX Copenhagen: “EXQ”) today announced results for the third quarter and first nine months of...
Major shareholder announcement
October 08, 2015 09:13 ET
|
Exiqon A/S
Copenhagen, 2015-10-08 15:13 CEST (GLOBE NEWSWIRE) --
Exiqon A/S, listed on NASDAQ Copenhagen (“EXQ”), has been informed by Teknoinvest VIII KS with its registered office at Smalgangen 3, 0188 Oslo,...
Storaktionærmeddelelse
October 08, 2015 09:13 ET
|
Exiqon A/S
Copenhagen, 2015-10-08 15:13 CEST (GLOBE NEWSWIRE) --
Exiqon A/S, der er noteret på NASDAQ Copenhagen (“EXQ”), meddeler, at Teknoinvest VIII KS med adresse på Smalgangen 3, 0188 Oslo, Norge...
Exiqon erhverver alle rettighederne til nye biomarkører for prostatakræft fra Århus Universitetshospital.
September 02, 2015 08:10 ET
|
Exiqon A/S
Copenhagen, 2015-09-02 14:10 CEST (GLOBE NEWSWIRE) --
Exiqon A/S (NASDAQ OMX Copenhagen: "EXQ") annoncerede i dag, at selskabet har udtaget eksklusiv licens til to sæt validerede biomarkør profiler...
Exiqon acquires all rights to new prostate cancer biomarkers from Aarhus University Hospital.
September 02, 2015 08:10 ET
|
Exiqon A/S
Copenhagen, 2015-09-02 14:10 CEST (GLOBE NEWSWIRE) --
Exiqon A/S (NASDAQ Copenhagen: “EXQ”) today announced that the company has exclusively licensed two sets of validated prostate cancer biomarkers...
Exiqon sætter analyse af menneskers genom på dagsordenen
August 26, 2015 01:58 ET
|
Exiqon A/S
Copenhagen, 2015-08-26 07:58 CEST (GLOBE NEWSWIRE) --
Den teknologiske udvikling inden for genetisk analyse er løbet forud for den offentlige debat af, hvad vi kan og vil bruge de nye teknologiske...
Continued strong performance in the second quarter with 24% growth and profitability
August 25, 2015 10:04 ET
|
Exiqon A/S
Copenhagen, 2015-08-25 16:04 CEST (GLOBE NEWSWIRE) --
Exiqon A/S (NASDAQ OMX Copenhagen: “EXQ”) today announced results for the second quarter and first six months of...
Exiqon launches ExiLERATE LNA™ qPCR product portfolio for analysis of mRNA and lncRNA
June 30, 2015 03:16 ET
|
Exiqon A/S
Copenhagen, 2015-06-30 09:16 CEST (GLOBE NEWSWIRE) --
Exiqon A/S (NASDAQ OMX: EXQ), a leading provider of flexible solutions for RNA analysis, today announced the launch of the ExiLERATE LNA™ qPCR...
Exiqon integrates RNAseq workflow in unique cloud-computing environment, XploreRNA™
June 30, 2015 02:54 ET
|
Exiqon A/S
Copenhagen, 2015-06-30 08:54 CEST (GLOBE NEWSWIRE) --
Exiqon A/S (NASDAQ OMX: EXQ), a leading provider of flexible solutions for RNA analysis, today announced the launch of its innovative XploreRNA™...
Exiqon integrerer RNA-sekvenserings work-flow i enestående cloud-løsning: XploreRNA™
June 30, 2015 02:54 ET
|
Exiqon A/S
Copenhagen, 2015-06-30 08:54 CEST (GLOBE NEWSWIRE) --
Exiqon A/S (NASDAQ OMX: EXQ), der er en førende leverandør af fleksible løsninger til RNA analyse, annoncerede i dag lanceringen af selskabets...